Department of Pathology, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada.
Hepatology. 2015 May;61(5):1696-707. doi: 10.1002/hep.27706. Epub 2015 Mar 18.
Repair of cirrhotic livers occurs, in part, by repopulation with hepatocytes through the stem/progenitor pathway. There remain many uncertainties regarding this pathway. Hepatocyte "buds" occurring in broad septa are hypothesized to be the anatomic manifestation of this pathway. Our purpose was to define a morphologic sequence of bud maturation to allow a quantitative measure of the importance of the stem/progenitor pathway in humans. Histologic sections from 37 liver resection specimens were stained with trichrome, epithelial cell adhesion molecule (EpCAM), K19, CD34, glutamine synthetase (GS), and Ki-67. Specimens were stratified by etiology (10 biliary, 22 nonbiliary, five controls) and stage. Buds were defined as clusters of hepatocytes within septa. Five levels of bud maturation (0-4) were defined by the progressive increase in hepatocyte progeny relative to cholangiocytes. Level 0 single-cell buds are K19(+) /GS(+) /EpCAM(+) /Heppar1(-) . In level 1, the progeny are morphologically hepatocytes (K19(-) /GS(+) /EpCAM(+) /Heppar1(+) ). In level 2-4 buds, hepatocytes increase and become progressively GS(-) and EpCAM(-) . Associated endothelium is CD34(+) in level 1-2 buds and becomes CD34(-) near hepatic veins in level 3-4 buds. Progeny of the bud sequence may represent up to 70% of hepatocytes (immaturity index of 70%). In biliary disease, bud number is reduced in association with duct loss and cholestatic destruction of nascent buds.
The stem/progenitor pathway, manifested anatomically by the bud sequence, is a major mechanism for repopulation of cirrhotic livers. The bud sequence reveals some critical features of hepatic morphogenesis, including that 1) the majority of distal cholangiocytes have stem-like properties, and 2) availability of bile ducts and/or venous drainage are limiting factors for regeneration.
肝硬化肝脏的修复部分是通过干细胞/祖细胞途径,使肝细胞再增殖来实现的。对于该途径仍存在许多不确定因素。广泛的间隔中出现的肝细胞“芽”被假设为该途径的解剖表现。我们的目的是确定芽成熟的形态学序列,以便对人类中干细胞/祖细胞途径的重要性进行定量测量。用三原色、上皮细胞黏附分子(EpCAM)、K19、CD34、谷氨酰胺合成酶(GS)和 Ki-67 对 37 例肝切除标本的组织学切片进行染色。标本按病因(10 例胆道,22 例非胆道,5 例对照)和分期分层。芽被定义为间隔内的肝细胞簇。通过相对胆管细胞逐渐增加的肝细胞后代,将芽成熟分为 5 个等级(0-4)。等级 0 的单细胞芽是 K19(+) /GS(+) /EpCAM(+) /Heppar1(-)。在等级 1 中,后代在形态上是肝细胞(K19(-) /GS(+) /EpCAM(+) /Heppar1(+))。在等级 2-4 的芽中,肝细胞逐渐增多,并逐渐 GS(-)和 EpCAM(-)。相关内皮细胞在等级 1-2 的芽中为 CD34(+),在等级 3-4 的芽中接近肝静脉时为 CD34(-)。芽序列的后代可能代表多达 70%的肝细胞(不成熟指数为 70%)。在胆道疾病中,与胆管丢失和新生芽的胆汁淤积性破坏相关,芽数量减少。
干细胞/祖细胞途径通过芽序列在解剖学上表现出来,是肝硬化肝脏再增殖的主要机制。芽序列揭示了肝发生的一些关键特征,包括 1)大多数远端胆管细胞具有干细胞样特性,2)胆管和/或静脉引流的可用性是再生的限制因素。